𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Systemic therapy for metastatic colorectal cancer : Current questions

✍ Scribed by Dan S. Zuckerman; Jeffrey W. Clark

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
204 KB
Volume
112
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A proliferation of new cytotoxic and biologic agents has led to improved survival in patients with metastatic colorectal cancer (mCRC). The ability of surgery to increase long‐term survival in patients with liver and/or lung metastases also has been firmly established. It has become increasingly difficult as the numbers and types of treatment options have expanded to identify optimal drug combinations, sequences, and duration and the best way to integrate systemic chemotherapy with potentially curative surgery for metastatic lesions. For this review, the authors examined how recent clinical trials have addressed some pertinent questions regarding the use of systemic chemotherapy and biologic agents in patients with mCRC. Cancer 2008. Β© 2008 American Cancer Society.

πŸ“œ SIMILAR VOLUMES

Hepatic trisegmentectomy for metastatic
Hepatic trisegmentectomy for metastatic colorectal cancer
✍ Thomas A. Nims πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 204 KB

## Abstract Radical Hepatic Resections For Metastatic Liver Disease Have Been Infrequently Done And Widely Criticized. Seven Patients Are Evaluated Who Had Trisegmentectomies Performed For Extensive Liver Metastases From Colorectal Primaries. There Was 1 Postoperative Death. Of The 6 Evaluable Pati

New systemic frontline treatment for met
New systemic frontline treatment for metastatic colorectal carcinoma
✍ Ada H. Braun; Wolf Achterrath; Hansjochen Wilke; Udo Vanhoefer; Andreas Harstric πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 166 KB πŸ‘ 1 views

## Abstract Options for first‐line chemotherapy in patients with metastatic colorectal carcinoma have broadened considerably with the introduction of irinotecan and oxaliplatin. Furthermore, the oral fluoropyrimidine capecitabine has demonstrated efficacy in Phase III trials and recently was approv

Hepatic resection following systemic che
Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma
✍ Wyatt C. Fowler; Burton L. Eisenberg; John P. Hoffman πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 384 KB

Increasingly effective systemic chemotherapy has improved responses in patients with previously unresectable colorectal hepatic metastases. In the future, response to chemotherapy may define a new population of patients that may benefit from hepatic resection. A retrospective review to determine the